*2.7. CTL Responses to Peptide Stimulation*

To evaluate the specific CD8+ T-cell response, an enzyme-linked immunosorbent spot (ELISPOT) assay was performed in six cases using a procedure reported in a prior study [11].


**Table 1.** Patient characteristics

*J. Clin. Med.* **2019** , *8*, 263

tested; OA rec, recurrent

recurrent tumor removal.

oligoastrocytoma;

 sGB, secondary glioblastoma;

 SRT, stereotactic radiotherapy;

 TMZ,

temozolomide;

 WT, wild type. \* This patient was enrolled after complete
